Search - tctmd.com

Displaying 121 - 140 of 236

Sort: Relevancy | Date

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

January 11, 2019

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

News Daily News

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

December 18, 2018

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

News Conference News AHA 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Michael O'Riordan

November 12, 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

News Daily News

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

September 11, 2018

CMS Advisory Panel Splits on TAVR Volume Requirements

News Daily News

CMS Advisory Panel Splits on TAVR Volume Requirements

July 26, 2018

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

July 23, 2018

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

News Daily News

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

July 18, 2018

FAST Public Health Campaign Fails to Improve Recognition of TIA, Minor Stroke

News Daily News

FAST Public Health Campaign Fails to Improve Recognition of TIA, Minor Stroke

July 09, 2018

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

CMS Taking Another Look at Volume Requirements for TAVR Programs

News Daily News

CMS Taking Another Look at Volume Requirements for TAVR Programs

June 28, 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Controversial Trial of Alcohol’s ‘Benefits’ for Preventing CVD Halted by NIH

News Daily News

Controversial Trial of Alcohol’s ‘Benefits’ for Preventing CVD Halted by NIH

June 19, 2018

FDA Advisory Panel Gives Thumbs Up to EVAR System

News Daily News

FDA Advisory Panel Gives Thumbs Up to EVAR System

June 14, 2018

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

To Cut CV Risk in Diabetes, Prescribe the Right Meds and Push for Lifestyle Changes

News Daily News

To Cut CV Risk in Diabetes, Prescribe the Right Meds and Push for Lifestyle Changes

Michael O'Riordan

April 17, 2018

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.